{"basic_info": {"ticker": "739", "exchange": "XSHE", "bloomberg_ticker": "000739 CH Equity", "name": "APELOA PHARMACEUTICAL CO-A", "industry": "Pharmaceuticals", "name_chinese_simplified": "普洛药业", "period": "2020", "market_value": 26222147584, "total_income": 7879672743, "ccy": "人民币元", "shariah_compliance_summary": "compliant"}, "business_activity_screening": {"summary": [{"shariah_compliance": "compliant", "income": 7746484715, "business_income_over_total_income": 0.9830972640179353}, {"shariah_compliance": "unknown", "income": 133188027, "business_income_over_total_income": 0.016902735855155806}], "details": [{"business_activity_cn": "中间体及原料药", "business_activity_en": "APIs and Intermediates", "income": 5931081686, "business_income_over_total_income": 0.7527066008253891, "shariah_compliance": "compliant"}, {"business_activity_cn": "合同研发生产服务", "business_activity_en": "Contract R & D services", "income": 1055249693, "business_income_over_total_income": 0.13392049738835202, "shariah_compliance": "compliant"}, {"business_activity_cn": "制剂", "business_activity_en": "preparation", "income": 760153336, "business_income_over_total_income": 0.09647016580419424, "shariah_compliance": "compliant"}, {"business_activity_cn": "其他", "business_activity_en": "other", "income": 105101516, "business_income_over_total_income": 0.013338309778584164, "shariah_compliance": "unknown"}, {"business_activity_cn": "其他业务", "business_activity_en": "Other business", "income": 28086511, "business_income_over_total_income": 0.003564426076571642, "shariah_compliance": "unknown"}, {"business_activity_cn": "合计特别调整", "business_activity_en": "Total special adjustments", "income": 0, "business_income_over_total_income": 0.0, "shariah_compliance": "unknown"}]}, "financial_screening": [{"item": "Debt to Market Capitalization", "amount": 0.04254575409421286, "shariah_compliance": "compliant", "amount_over_market_value": 0.04254575409421286}]}